Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
58 This information is an important component to establish a diagnosis of IC/BPS, provides a baseline against which treatments can be evaluated, and is used to determine the appropriate level of entry into the treatment algorithm
Moreover, TB-500 also appeared to have promoted the expression of CD31, -smooth muscle actin (-SMA), Ang2, tie2, VEGFA, N1ICD, and p-p65 in the muscle tissues of murine CLI models
Epidemiology Gamma-glutamylcysteine synthetase deficiency is very rare disease
Regular exercise depletes muscle glycogen stores, lowers blood glucose, and improves glycemic control in T2DM over 8 weeks or more
Imfinzi (durvalumab) Disease area(s): Oncology Manufacturer(s): AstraZeneca 2024 Sales (USD): $4.72 billion Why it sold so well: In 2024, AstraZenecas Imfinzi experienced strong sales growth, driven by expanded indications and robust clinical trial results
US$ 21.67
US$ 24.25
US$ 23.41
US$ 28.56
US$ 25.08
